Table 6.
Average antibody titre (log2) to classical rabbit haemorrhagic disease virus (RHDV1), the new RHDV genotype (RHDV2) and myxoma virus in NZW rabbits.
| Treatment Group | Titre to RHDV1 | Titre to RHDV2 | Titre to Myxoma Virus | |||||
|---|---|---|---|---|---|---|---|---|
| Challenge Virus | - | Group | Day 0 or 28 ǂ | Day 49 | Day 0 or 28 ǂ | Day 49 | Day 0 or 28 ǂ | Day 49 |
| RHDV1 Ascot | Vaccinates | 1 | <1 * | 3.3 | <1 | 5.1 | <6 # | 9.9 |
| Controls | 2 | <1 | <1 | <1 | <1 | <6 | <6 | |
| RHDV1 Ascot | Vaccinates | 3 | <1 | 2.4 | <1 | 4.5 | <6 | 12.4 |
| Controls | 4 | <1 | <1 | <1 | <1 | <6 | <6 | |
| RHDV2 Spain | Vaccinates | 5 | <1 | 3.0 | <1 | 3.8 | <6 | 12.4 |
| Controls | 6 | <1 | <1 | <1 | <1 | <6 | <6 | |
| RHDV2 Italy2 | Vaccinates | 7 | <1 | 2.4 | <1 | 4.0 | <6 | 11.2 |
| Controls | 8 | <1 | <1 | <1 | <1 | <6 | <6 | |
* For RHDV a titre <1 is considered negative; # for myxoma virus a titre <6 is considered negative; ǂ blood was sampled prior to vaccination for group 1 and 2 at day 0 and for group 3–8 at day 28.